Sleep and Suicide in Older Adults: An Opportunity for Intervention
Whether as a standalone disorder or as a symptom associated with existing pathology, the prevalence of sleep disturbance increases with age. Older adults also experience a myriad of risk factors for suicide, including depression, and have elevated rates of suicide. There is now significant evidence linking sleep disturbances to suicidal thoughts and behaviors. The use of pharmacologic means to treat insomnia (e.g., sedative hypnotics) is also commonplace among older cohorts and has been associated with suicide. Behavioral treatment of insomnia represents an efficacious alternative to pharmacotherapy among older adults, which while improving sleep, may concurrently reduce depressive symptomatology. Implications and clinical recommendations of the sleep-suicide relationship are discussed..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Clinical therapeutics - 38(2016), 11, Seite 2332-2339 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bishop, Todd M [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1016/j.clinthera.2016.09.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1984484877 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1984484877 | ||
| 003 | DE-627 | ||
| 005 | 20230512173838.0 | ||
| 007 | tu | ||
| 008 | 161202s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinthera.2016.09.015 |2 doi | |
| 028 | 5 | 2 | |a PQ20161201 |
| 035 | |a (DE-627)OLC1984484877 | ||
| 035 | |a (DE-599)GBVOLC1984484877 | ||
| 035 | |a (PRQ)c1001-d5b4cd87e058571ade38ae48c71f0c9744b48066b9776a26024ec48e0b3c32980 | ||
| 035 | |a (KEY)0040169220160000038001102332sleepandsuicideinolderadultsanopportunityforinterv | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Bishop, Todd M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sleep and Suicide in Older Adults: An Opportunity for Intervention |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Whether as a standalone disorder or as a symptom associated with existing pathology, the prevalence of sleep disturbance increases with age. Older adults also experience a myriad of risk factors for suicide, including depression, and have elevated rates of suicide. There is now significant evidence linking sleep disturbances to suicidal thoughts and behaviors. The use of pharmacologic means to treat insomnia (e.g., sedative hypnotics) is also commonplace among older cohorts and has been associated with suicide. Behavioral treatment of insomnia represents an efficacious alternative to pharmacotherapy among older adults, which while improving sleep, may concurrently reduce depressive symptomatology. Implications and clinical recommendations of the sleep-suicide relationship are discussed. | ||
| 650 | 4 | |a Insomnia | |
| 650 | 4 | |a Restless legs syndrome | |
| 650 | 4 | |a Age | |
| 650 | 4 | |a Sleep disorders | |
| 650 | 4 | |a Suicides & suicide attempts | |
| 650 | 4 | |a Womens health | |
| 650 | 4 | |a Aging | |
| 650 | 4 | |a Adults | |
| 650 | 4 | |a Hispanics | |
| 650 | 4 | |a Manuscripts | |
| 650 | 4 | |a Conflicts of interest | |
| 650 | 4 | |a Mens health | |
| 650 | 4 | |a Behavior modification | |
| 650 | 4 | |a Sleep apnea | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Older people | |
| 650 | 4 | |a Drugs | |
| 650 | 4 | |a Mental depression | |
| 650 | 4 | |a Anxieties | |
| 700 | 1 | |a Simons, Kelsey V |4 oth | |
| 700 | 1 | |a King, Deborah A |4 oth | |
| 700 | 1 | |a Pigeon, Wilfred R |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical therapeutics |d Amsterdam [u.a.] : Elsevier, 1977 |g 38(2016), 11, Seite 2332-2339 |w (DE-627)130396931 |w (DE-600)603113-4 |w (DE-576)015899691 |x 0149-2918 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2016 |g number:11 |g pages:2332-2339 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.clinthera.2016.09.015 |3 Volltext |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1841759977 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 38 |j 2016 |e 11 |h 2332-2339 | ||